Dr. Venkat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1150 NW 12th Ave
Suite 702A
Miami, FL 33136Phone+1 305-243-5593Fax+1 305-243-5595
Summary
- Shree Venkat, MD is an Assistant Professor of Interventional Radiology at University of Miami-Miller School of Medicine. She was born in Brooklyn, New York and grew up in Detroit, Michigan. After obtaining a BSE in Chemical engineering, and a BA in English Language and Literature at University of Michigan, she completed medical school at Wayne State University School of Medicine in Detroit. After residency, she completed her Interventional radiology (VIR) fellowship at University of Miami-Miller School of Medicine where she continues to practice.
Dr. Venkat is Board-Certified in Diagnostic radiology with a Certificate of Added Qualification (CAQ) in Vascular and Interventional Radiology from the American Board of Radiology. Her research interests favor interventional oncology techniques to manage localized cancer with focus on chemoembolization, and tumor ablation. In this field of study, she has coauthored several publications in peer-reviewed journals as well as given invited talks in scientific meetings for example at Synergy and AIM symposium in 2016. Clinical service is also balanced with participation on the Clinical Competency committee for the VIR fellowship program.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Vascular and Interventional Radiology, 2012 - 2013
- University of ToledoResidency, Radiology-Diagnostic, 2008 - 2012
- Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2007 - 2008
- Wayne State University School of MedicineClass of 2007
Certifications & Licensure
- FL State Medical License 2013 - 2025
- OH State Medical License 2008 - 2012
- MI State Medical License 2007 - 2008
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- Best Poster Award in Splenic Artery Embolization for Thrombocytopenia in Chemo Therapy Society of Interventional Radiology, 2013
- Resident Award Jason Sheehan, 2012
Clinical Trials
- A Clinical Study of Precision TACE (P-TACE) With Surefire Start of enrollment: 2018 May 01
Publications & Presentations
PubMed
- 85 citationsPercutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic AdenocarcinomaGovindarajan Narayanan, Peter J. Hosein, Isabelle C. Beulaygue, Tatiana Froud, Hester J. Scheffer
Journal of Vascular and Interventional Radiology. 2017-03-01 - 35 citationsUnresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.Laila Lobo, Danny Yakoub, Omar Picado, Caroline Ripat, Fiorella Pendola
Cardiovascular and Interventional Radiology. 2016-11-01 - 30 citationsSafety and efficacy of the PleurX catheter for the treatment of malignant ascitesGovindarajan Narayanan, Amir Pezeshkmehr, Shree Venkat, Gabriella Guerrero, K.J. Barbery
Journal of Palliative Medicine. 2014-08-01
Journal Articles
- Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and managementAnkit Mehta , Shree R. Venkat , Lorraine Portelance , Lynn G. Feun, Publication, 2/27/2018
- Pancreatic Irreversible Electroporation: An Alternative to Pancreatic MetastasectomyShree Venkat and Govindarajan Naryanan, Publication, 4/1/2015
- Treatment Options for Thrombocytopenia in Cancer PatientsShivank Bhatia, MD, Shree Venkat, MD, Caio Max Rocha-Lima, MD, Eduardo Gonzalez, MD, Emily Jun, MD, Govindarajan Narayanan, MD, Publication, 12/19/2013
Authored Content
- Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management.February 2018
- Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and managementFebruary 2018
Committees
- Assistant Director of DR Program, University Committee and Administrative Responsibilities 2018 - Present
- Interim Clinical Service Leader, IR, Interventional Oncology, University Committee and Administrative Responsibilities 2018 - 2020
- Director of Interventional Radiology Quality Assurance and Information Technology, University of Committee and Administrative Responsibilities 2017 - 2019
Research History
- Sub-Investigator, lnterventional Radiologist performing RadioembollzationREAD90Y Registry
- Sub-Investigator, Biopsies and lntratumoral injectionsVSV-IFNj3-NIS_ VYRIAD
- Biopsies and lntratumoral injectionsThe Toca 6 Study: A Phase 1 b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects with Solid Tumors
- Sub-Investigator, lnterventional Radiologist performing RadioembolizationTheraSphere® for Unresectable Liver Neoplasia
- Sub-Investigator, lnterventional Radiologist performing RadioembolizationSirtex Resin Study
- Principal InvestigatorRetrospective review of Y90 cases
- Sub-Investigator, lnterventional Radiologist performing PancreaticA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
- Sub-Investigator, lnterventional Radiologist performing Acoustic Pulse ThrombolysisKNOCOUT PE
- Sub-Investigator, lnterventional Radiologist placing IVC filtersPRESERVE
- Sub-Investigator, Biopsies and lntratumoral injectionsE7766-G000-101 : A Phase 1/1b Study of lntratumorally Administered STING Agonist E7766 in Subjects With Advanced Solid Tumors or Lymphomas
- Sub-Investigator, Biopsies and lntratumoral injectionsJX594-REN026: A Study of Recombinant Vaccinia Virus in Combination With REGN2810 for Renal Cell Carcinoma
- Sub-Investigator, Biopsies and lntratumoral injectionsIM-202: A Randomized, Open-Label, Multicenter, Phase 1 b/2 Trial Evaluating The Safety and Efficacy of lntratumorally-Administered llixadencel In Combination With Checkpoint lnbitor (CPI)
- Sub-InvestigatorUnified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma and Cholangiocarcinoma
- Sub Investigator, Biopsies and Intratumoral InjectionsRPL-001-16: An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors
Professional Memberships
- Society of Interventional RadiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: